Clinical Trial Update: Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral vitamin C (ascorbic acid) for correcting anemia in patients receiving peritoneal dialysis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Unity Health Toronto | Conditions: Anemia, Peritoneal Dialysis | Phase 3 | Status: COMPLETED